MedPath

The effects of magnesium supplement on muscle strength, muscle function, and inflammatory markers in middle-aged women.

Phase 3
Conditions
Decrease of muscle strength.
Muscle wasting and atrophy, not elsewhere classified
Registration Number
IRCT138805312365N1
Lead Sponsor
Iran Univesity of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
80
Inclusion Criteria

1. Age 45 to 55 years old 2. Stopped menstrual cycle for at least 12 month 3. Voluntary participation
Exclusion criteria: 1. BMI less than 25 Kg/m2 2. Having one of the following diseases: uncontrolled hypertension, Diabetes, cardiovascular diseases, asthma, Thyroid or parathyroid diseases, renal disorders, liver diseases, bone or rheumatoid disorders, gastrointestinal diseases, and infectious diseases 3. Taking any supplements including minerals, vitamins, and ?-3 fatty acids 4. Receiving hormonal products 5. Cigarette smoking 6. Using one of the following medications: anti-inflammatory drugs (including NSAIDs, steroids, salicylates), aminoglycosides antibiotics, Laxative drug, magnesium-containing drugs 7. compliance less than 70%

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Muscle strength in hand and foot. Timepoint: 8 weeks. Method of measurement: Dynamometer, Handgrip.
Secondary Outcome Measures
NameTimeMethod
Inflamentory markers. Timepoint: 8 weeks after intervention. Method of measurement: decline of inflamentory marker.
© Copyright 2025. All Rights Reserved by MedPath